Titre:
  • Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial.
Auteur:Pajk, Bojana; Cufer, T; Canney, P A; Ellis, P.; Cameron, David A; Blot, Emmanuel; Vermorken, Jan Baptist; Coleman, R; Marreaud, Sandrine; Bogaerts, J; Basaran, Gul; Piccart-Gebhart, Martine
Informations sur la publication:Breast, 17, 2, page (180-185)
Statut de publication:Publié, 2008-04
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Breast cancer
Capecitabine
Efficacy
Monotherapy
Toxicity
Vinorelbine
MeSH keywords:Adult
Aged
Anthracyclines -- therapeutic use
Antimetabolites, Antineoplastic -- administration & dosage
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- pathology
Bridged Compounds -- therapeutic use
Deoxycytidine -- administration & dosage
Deoxycytidine -- analogs & derivatives
Drug Therapy, Combination
Female
Fluorouracil -- administration & dosage
Fluorouracil -- analogs & derivatives
Humans
Middle Aged
Taxoids -- therapeutic use
Treatment Outcome
Vinblastine -- administration & dosage
Vinblastine -- analogs & derivatives
Note générale:Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0960-9776
info:doi/10.1016/j.breast.2007.09.002
info:pii/S0960-9776(07)00193-2
info:scp/41549104608
info:pmid/17976988